Daniel Tanner
Nurse Practitioner · Plymouth, INNPI 1760731798
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,846 of the $13,084 with a category attached, or 67.6%. 44 manufacturers reported payments, led by Genentech USA, Inc. at 29.3% of the total. Reporting peaked in 2021 at $6,447 and has fallen 82.4% since, to $1,136 in 2025. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 512 payments — averaging $25.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$4K
- AbbVie$2K
- Bayer$1K
- Novo Nordisk$749
- Lilly USA, LLC$516
- Boehringer Ingelheim$491
- plus $4K from 38 others
What the payments were for
- Speaking & faculty fees$3,87130%
- Travel & lodging$3072%
- Food & beverage$8,84668%
- Education$600%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,084 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 39 | $50,028 |
| MounjaroTirzepatide | 42 | $48,875 |
| JardianceEmpagliflozin | 23 | $23,324 |
| RexultiBrexpiprazole | 12 | $17,857 |
| KerendiaFinerenone | 19 | $17,428 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $14,837 |
| QuliptaAtogepant | 12 | $12,593 |
| Repatha SureclickEvolocumab | 11 | $7,138 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $635 |
| Levothyroxine Sodium | 64 | $571 |
| Hydroxychloroquine Sulfate | 14 | $507 |
| Pantoprazole Sodium | 37 | $420 |
| Amitriptyline Hcl | 13 | $411 |
| Pregabalin | 15 | $341 |
| Cephalexin | 11 | $338 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $749 | $50,02839 claims |
| Lilly USA, LLCMounjaro | $516 | $48,87542 claims |
| Boehringer IngelheimJardiance | $491 | $23,32423 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $205 | $17,85712 claims |
| BayerKerendia | $1,081 | $17,42819 claims |
| GSKTrelegy Ellipta | $272 | $14,83719 claims |
| AbbVieQulipta | $1,941 | $12,59312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Plymouth
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.